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Background: A comparison of post-heparin and pre-heparin plasma lipoprotein lipase (LPL) and hepatic
triglyceride lipase (HTGL) on the metabolism of remnant lipoproteins (RLPs) has not been reported yet.
Methods: Healthy volunteers were injected with heparin for LPL and HTGL determination in the fasting (8:00)
and postprandial (20:00) plasma on the same day. Plasma total cholesterol (TC), triglycerides (TG), LDL-C,
HDL-C, small dense LDL (sdLDL)-C, remnant lipoprotein (RLP)-C, RLP-TG, the RLP-TG/RLP-C ratio, adiponectin
and apoCIII were measured.
Results: LPL activity and concentration in the post-heparin plasma exhibited a signiﬁcant inverse correlationwith
TG, RLP-C, RLP-TG, and RLP particle size estimated as RLP-TG/RLP-C ratio and sdLDL-C, and positively correlated
with HDL-C. HTGL was only inversely correlated with HDL-C. LPL concentration in the pre-heparin plasma was
also inversely correlated with the RLP-TG/RLP-C ratio and other lipoprotein parameters. Adiponectin was
inversely correlated with RLP-TG/RLP-C ratio and apoC III was positively correlated with RLP-TG/RLP-C ratio,
but not correlated with LPL activity.
Conclusion: LPL activity and concentrationwere inversely and signiﬁcantly correlatedwith the particle size of RLP
in both the post-heparin and pre-heparin plasma. Those results suggest that LPL concentration in pre-heparin
plasma can take the place of LPL activity in the post-heparin plasma.© 2014 Published by Elsevier B.V.1. Introduction
Remnant lipoprotein (RLP) metabolism is known to be regulated by
lipoprotein lipase (LPL) andhepatic triglyceride lipase (HTGL) [1–3]. LPL
plays a central role in triglyceride-rich lipoproteins (TRLs) metabolism
by catalyzing the hydrolysis of triglycerides (TG) in chylomicrons
(CMs) and very low-density lipoprotein (VLDL) particles and is a useful
biomarker in diagnosing Type I hyperlipidemia [4] and also prediction
of cardiovascular diseases [5]. HTGL has been recognized to play a role
in catalyzing the hydrolysis of the smaller remnants into LDL [6]. We
previously reported that postprandial RLPs in a 4 h period after a fat
load are signiﬁcantly larger in particle size compared to the fasting
state, with a TG increase in RLPs [7]. The interaction of those lipase
activities with the associated lipoproteins and RLP particle size in the
fasting and postprandial plasma was the focus of this investigation.
The accumulation of RLPs of large particle size after an oral fat load is
mainly due to the delayed metabolism of VLDL by LPL [7,8]. LPL andisease Research Center, Hidaka
001. Tel.: +81 90 2893 6429.
awa).HTGL activities and concentrations, bothwith andwithout a heparin in-
jection, were pursued in order to elucidate the plasma TRL metabolism,
especially in terms of the effect on the RLP particle size, estimated by
RLP-TG/RLP-C ratio compared with HPLC assay by Okazaki et al. [9].
If there is a close similarity between the RLP particle size in pre- and
post-heparin plasma, it may be possible to eliminate the heparin injec-
tion that is commonly used tomeasure LPL andHTGL activities and con-
centrations for clinical diagnostic purposes. Non-heparinized plasma
(pre-heparin plasma) is known to contain a considerably large amount
of LPL, but the activity of TG hydrolysis is very low or non-detectable.
Watson et al. [10] tried to measure this low level of LPL activity by
increasing the serum volume and prolonging the incubation time,
but they still did not ﬁnd a meaningful association between the pre-
heparin LPL activity and the lipoprotein concentrations, suggesting
that the plasma LPL concentration does not reﬂect a signiﬁcant role in
lipid metabolism, at least via its lipolytic activity.
However, recent studies have revealed that catalytically inactive
LPL in pre-heparin plasma can act as a ligand for lipoprotein recep-
tors and glucosaminoglycans in the liver [11–15]. Thus, catalytically
inactive LPL might participate in lipoprotein metabolism via its
ligand function rather than its lipolytic function. Because it is
194 T. Shirakawa et al. / Clinica Chimica Acta 440 (2015) 193–200catalytically inactive, the measurement of pre-heparin LPL concentration
has not received much attention as a diagnostic marker in clinical
laboratories, despite the extensive studies reported by Shirai and
et al. [16–23] and others [24,25].
2. Materials and methods
2.1. Study subjects
The study in relatively healthy young volunteers (some cases were
overweight or obese) in a male (n= 36) and female (n= 40) popula-
tion (Caucasian 45, Asian 10, Hispanic 9, African American 7, others 5)
with a median age of 24 and BMI of 24 at the University of California,
Davis (Table 1). Inclusion criteria included age from 18 to 40 y and
BMI of 18–35 kg/m2 with a self-report of stable body weight during
the prior 6 months. Exclusion criteria included evidence of diabetes,
renal disease, or hepatic disease; fasting serum TG concentrations
greater than 400 mg/dl; hypertension (N140/90 mm Hg); and history
of surgery for weight loss. Individuals who smoked, reported exercise
of N3.5 h/week at a level more vigorous than walking, or reported hav-
ing used thyroid, lipid-lowering, glucose-lowering, antihypertensive,
antidepressant, orweight-lossmedicationswere also excluded. Seventy
six volunteers were injected with heparin for the LPL and HTGL activity
assays. The University of California at Davis Institutional Review
Board approved the experimental protocol and the subjects provided
written informed consent to participate in the study. Baseline blood
samples of fructose and glucose study by Stanhope et al. [26] were
provided for this study and all the parameter analysis were performed
at Gunma University.
Fasting blood sampleswere collected at 08:00 h before breakfast and
postprandial blood samples were collected at 20:00 h after dinner on
the same day. During the day, standardized meals were provided as
breakfast, lunch and dinner to all of the volunteers. The energy content
of the meals was based on each subject's energy requirements as
determined by the Mifﬂin equation [27].
2.2. Determination of lipids and lipoproteins as well as lipase activities
and concentrations
The plasma samples for the measurement of TC, TG, HDL-C, LDL-C,
RLP-C, RLP-TG and sdLDL-C were withdrawn before (pre-heparin
plasma) and after heparin injection (post-heparin plasma) and kept
frozen at −80 °C until analysis. As LPL and HTGL activities were not
detectable in the pre-heparin plasma, all of the lipase activities in this
study were determined in the post-heparin plasma by the method
of Imamura [28]. Brieﬂy, the post-heparin plasma was withdrawn
15 min after the intravenous injection of 50 units of heparin/kg body
weight for the assay of LPL, HTGL activity and concentration. The LPL
and HTGL activity assays were an automated kinetic colorimetric
method in post-heparin plasma by using a natural long-chain fatty
acid, 1,2-diglyceride as substrate for assaying HL activity and with the
presence of apoC-II for assaying LPL activity. LPL activity was calculated
after subtracted HTGL activity from total lipase activity after adding apoTable 1
Clinical characteristics of 76 volunteers.
Median (25%tile–75%tile)
Age (y) 24 (22–30)
Gender male/female 36/40
Body weight (kg) 73 (61–82)
BMI 24 (22–27)
Abdominal circumference (cm) 77 (67–81)
Blood pressure
Systolic (mm Hg) 117 (110–130)
Diastolic (mm Hg) 72 (67–76)CII. LPL and HTGL hydrolyzed the clear substrate solution to produce a
2-monoglyceride, which in turn releases glycerol by the action of a
2-monoglyceride lipase. The glycerol produced is then assayed by a se-
quence of enzymatic actions that produce a violet quinone monoimine
dye. The accuracy and stability of this activity assay were reported pre-
viously by Imamura et al. [28]. The pre-heparin LPL and HTGL concen-
trations were determined by the highly sensitive and speciﬁc ELISA kit
(IBL, Fujioka, Japan) recently developed by Miyashita et al. [29]. The
TC and TG concentrations were determined enzymatically. The LDL-C
andHDL-C concentrationsweremeasuredusing a homogenousmethod
(Kyowa Medex, Tokyo). Glucose and insulin were determined by
PolyChem (Polymedco, NY). RLP-C and RLP-TG were determined by
an immunoseparation method (JIMRO II, Otsuka, Tokyo) [30]. Small
dense LDL-C was determined by the method of Ito et al. [31].
2.3. Statistical analysis
Datawere analyzedwith Dr. SPSS II (SPSS).The data are presented as
median values with 25th and 75th percentile values, rather than as
mean values with standard deviation. The statistical signiﬁcance of
difference was determined by Mann–Whitney U-test. Pearson's
correlation coefﬁcients (r = value) were determined and single
linear regression analysis was performed to detect associations
between variables. P b 0.05 was considered statistically signiﬁcant.
3. Results
3.1. Post-heparin plasma lipids, lipoproteins, LPL and HTGL activity and
concentration analyses in the fasting and postprandial states.
Table 1 indicates the demographic data on 76 volunteers recruited at
UC Davis, CA. Table 2 indicates that the mean total cholesterol (TC),
LDL-C and HDL-C levels were within a normal range in the fasting and
postprandial plasma. TG, RLP-C, and RLP-TG were signiﬁcantly elevated
in the postprandial plasma, but TC, LDL-C, HDL-C and sdLDL-C did
not change. RLP-TG/RLP-C ratio in the postprandial plasma increased
2.6 fold compared to the fasting plasma both in pre-heparin and post-
heparin plasma. LPL activity was signiﬁcantly reduced in the postpran-
dial plasma, but LPL concentration was not. HTGL activity and concen-
tration were unchanged in the postprandial plasma. Both LPL and
HTGL activities were not detected in pre-heparin plasma. HTGL concen-
tration was detected negligible level compared to LPL concentration in
pre-heparin plasma.
3.2. A single linear regression analysis of these parameters in the
post-heparin and pre-heparin plasma.
A). TG correlations with the post-heparin and pre-heparin LPL and
HTGL activities and concentrations in the fasting and postprandial
plasma.
In post-heparin plasma (Table 3), TG concentration was inversely
and signiﬁcantly correlated with LPL activity and concentration in
both the fasting and postprandial plasma, respectively, while no corre-
lation was found with HTGL activity or concentration in either the
fasting or postprandial plasma.
In pre-heparin plasma (Table 4), TG concentration was inversely
correlated with LPL concentration in both the fasting and signiﬁcantly
correlated in postprandial plasma, while no correlation was found
with HTGL concentration in either the fasting or postprandial plasma.
B). RLP-C correlations with the post-heparin and pre-heparin LPL
and HTGL activities and concentrations in the fasting and postprandial
plasma
In post-heparin plasma (Table 3), RLP-C was inversely and signiﬁ-
cantly correlated with the LPL activity and concentration in the fasting
and postprandial plasma respectively, while no correlation was found
with HTGL activity in either.
Table 2
Post-heparin and pre-heparin plasma lipids, lipoproteins, LPL and HTGL activities and concentrations in the fasting and postprandial states.
Post-heparin
plasma
Fasting (8:00) Postprandial (20:00) p Pre-heparin plasma Fasting (8:00) Postprandial (20:00) p
Median (25%tile–75%tile) Median (25%tile–75%tile) Median (25%tile–75%tile) Median (25%tile–75%tile)
TC (mg/dl) 160 (142–181) 159 (146–183) NS TC (mg/dl) 164 (144–187) 165 (149–187) NS
TG (mg/dl) 47 (31–74) 73 (45–105) 0.001 TG (mg/dl) 74 (49–100) 108 (73–150) b0.001
Hdl-C (mg/dl) 47 (42–59) 47 (41–58) NS Hdl-C (mg/dl) 48 (44–61) 48 (43–61) NS
Ldl-C (mg/dl) 90 (71–107) 91 (73–107) NS Ldl-C (mg/dl) 90 (73–108) 92 (73–107) NS
sdldl-C (mg/dl) 21.4 (17.2–30.9) 24.3 (19.4–34.6) NS sdldl-C (mg/dl) 22.3 (17.6–32.5) 25.1 (19.4–35.3) NS
RLP-C (mg/dl) 3.5 (2.5–4.8) 4.6 (3.5–6.7) b0.001 RLP-C (mg/dl) 3.4 (2.7–5.0) 5.5 (3.8–7.5) b0.001
RLP-TG (mg/dl) 4.2 (2.4–6.8) 14.5 (8.1–27.0) b0.001 RLP-TG (mg/dl) 8.7 (5.3–14.3) 38.3 (23.6–66.4) b0.001
RLP-TG/RLP-C 1.4 (0.7–2.0) 3.6 (1.9–5.2) b0.001 RLP-TG/RLP-C 2.6 (1.6–3.5) 8.2 (5.4–11.3) b0.001
LPL (U/l) 78.9 (68.7–89.3) 65.9 (57.5–77.5) b0.001 LPL (U/l) – – – – –
LPL (ng/ml) 206 (179–248) 205 (173–237) NS LPL (ng/ml) 27.9 (21.0–34.9) 32.0 (25.7–42.5) 0.003
HTGL (U/l) 222 (170–287) 202 (141–252) NS HTGL (U/l) – – – – –
HTGL(ng/ml) 146 (90–195) 166 (107–238) NS HTGL (ng/ml) 0.6 (0.3–1.5) 0.7 (0.4–1.7) NS
Adiponectin (μg/ml) 7.7 (6.2–10.5) 7.5 (6.1–10.8) NS Adiponectin (μg/ml) 8.7 (6.9–12.3) 8.4 (7.0–11.5) NS
ApoCIII(mg/dl) 8.3 (6.9–9.9) 8.0 (6.6–9.3) NS ApoCIII(mg/dl) 7.7 (6.9–9.2) 7.1 (6.2–9.0) 0.050
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HTGL concentration were inversely correlated with LPL concentration
in both the fasting and postprandial plasma, respectively, while no
correlation was found with HTGL concentration in either.
C). RLP-TG correlations with the post-heparin and pre-heparin
plasma LPL and HTGL activities and concentrations in the fasting and
postprandial plasma
In post-heparin plasma (Table 3), RLP-TG was inversely and signiﬁ-
cantly correlated with LPL activity and concentration in both the fasting
and postprandial plasma, respectively, and positively correlated with
HTGL concentration in the postprandial plasma (not correlated in the
fasting plasma, but positively correlated in the postprandial plasma).
The positive correlation between RLP-TG and HTGL activities means
that HTGL does not hydrolyze RLP-TG.
In pre-heparin plasma (Table 4), RLP-TG was inversely and signiﬁ-
cantly correlated with LPL concentration in both the fasting and
postprandial plasma. The correlation with RLPs and HTGL was not able
to calculate because of the negligible concentration of HTGL in pre-
heparin plasma. Those results indicated that HTGL did not play a signif-
icant role in RLP metabolism in both pre-and post-heparin plasma.
D). sdLDL-C correlations with the post-heparin and pre-heparin
plasma LPL and HTGL activities and concentration in the fasting and
postprandial plasma
In post-heparin plasma (Table 3), sdLDL-C was inversely and sig-
niﬁcantly correlated with LPL activity and concentration in the
fasting, but not in the postprandial plasma, while no correlation
was found with HTGL activity in either the fasting or postprandial
plasma. Furthermore, sdLDL-C with TG, RLP-C and RLP-TG were
positively and signiﬁcantly correlated with both in the fasting and
postprandial plasma.
In pre-heparin plasma (Table 4), sdLDL-C was inversely and signiﬁ-
cantly correlated with LPL concentration in both the fasting and
postprandial plasma, while no correlationwas foundwith HTGL activity
in either the fasting or postprandial state. Furthermore, sdLDL-C was
positively and signiﬁcantly correlated with TG, RLP-C and RLP-TG in
both the fasting and in the postprandial state, respectively.
E). HDL-C correlations with the post-heparin and pre-heparin
plasma LPL and HTGL activities and concentrations in the fasting and
postprandial plasma
In post-heparin plasma (Table 3), HDL-C was positively and signiﬁ-
cantly correlated with LPL activity and concentration in the fasting
and postprandial plasma and inversely and signiﬁcantly correlated
with HTGL activity and concentration in both the fasting and postpran-
dial plasma. In pre-heparin plasma (Table 4), HDL-C was positively and
signiﬁcantly correlated with the LPL concentration in the fasting and
postprandial plasma and there was no correlation with HTGL in the
fasting and postprandial plasma because of the negligible concentration
of HTGL in pre-heparin plasma.3.3. Correlations of RLP-TG/RLP-C ratio with LPL and HTGL activities and
concentrations in the post-heparin and pre-heparin plasma LPL
In post-heparin plasma, the RLP-TG/RLP-C ratio was inversely and
signiﬁcantly correlated with LPL activity and concentration in the
fasting and postprandial plasma, respectively (Fig. 1), while no correla-
tion was found with HTGL activity and concentration in either the
fasting and postprandial plasma activity, but correlated positively in
postprandial HTGL concentration (Fig. 2). Positive correlation means
that HTGL does not play a role to hydrolyze RLP.
In pre-heparin plasma, the RLP-TG/RLP-C ratio was inversely and
signiﬁcantly correlated with LPL concentration in the fasting and post-
prandial plasma (Fig. 3) as correlated with LPL activity. Neither HTGL
activity nor concentration was detected in pre-heparin plasma.
3.4. Correlations of RLP-TG/RLP-C ratio with the adiponectin and apoC III in
the post-heparin plasma
In post-heparin plasma, the RLP-TG/RLP-C ratio was inversely and
signiﬁcantly correlated with adiponectin in both the fasting and post-
prandial plasma (Table 3). In pre-heparin plasma, the RLP-TG/RLP-C
ratio was inversely and signiﬁcantly correlated with adiponectin in
both the fasting and postprandial plasma (Table 4; Fig. 4).
RLP-TG/RLP-C ratio in post-heparin plasma was positively and sig-
niﬁcantly correlatedwith apoCIII in the fasting and postprandial plasma
(Table 3). RLP-TG/RLP-C ratio in pre-heparin plasmawas also positively
and signiﬁcantly correlated with apoCIII in the fasting, but not signiﬁ-
cantly in the postprandial plasma (Table 4).
3.5. Correlations of LPL activity and concentrationwith the adiponectin and
apoCIII in the post-heparin plasma
In post-heparin plasma, LPL activity was not correlated with
adiponectin in either the fasting or postprandial plasma (Table 3). How-
ever, in pre-heparin plasma, LPL concentration was positively and sig-
niﬁcantly correlated with adiponectin in the fasting and postprandial
plasma (Table 4; Fig. 5).
In post-heparin plasma, LPL activity was not signiﬁcantly correlated
with apoCIII in both the fasting or postprandial plasma (Table 3). Also in
pre-heparin plasma, LPL concentration was also not correlated with
apoCIII in both fasting and postprandial plasma (Table 4), indicating
no direct inhibitory effect of apoCIII on LPL activity.
4. Discussion
We reported previously that postprandial RLPs increased signiﬁcant-
ly after food intake and exhibited a 4.4 fold increase of RLP-TG/RLP-C
Table 3
A single regression analysis of these parameters in post-heparin fasting and postprandial plasma.
TG HDL-C sdLDL-C RLP-C RLP-TG RLP-TG/RLP-C LPL (activity) LPL (concentration) HTGL (activity) HTGL (concentration) Adiponectin ApoCIII
Fasting (8:00)
TG
HDL-C −0.360⁎⁎
sdLDL-C 0.657⁎⁎⁎ −0.287⁎
RLP-C 0.455⁎⁎⁎ −0.245⁎ 0.512⁎⁎⁎
RLP-TG 0.877⁎⁎⁎ −0.440⁎⁎⁎ 0.496⁎⁎⁎ 0.477⁎⁎⁎
RLP-TG/RLP-C 0.734⁎⁎⁎ −0.341⁎⁎ 0.260⁎ −0.012 0.836⁎⁎⁎
LPL (activity) −0.566⁎⁎⁎ 0.198 −0.262⁎ −0.313⁎⁎ −0.513⁎⁎⁎ −0.408⁎⁎⁎
LPL (concentration) −0.432⁎⁎⁎ 0.399⁎⁎⁎ −0.146 −0.171 −0.473⁎⁎⁎ −0.422⁎⁎⁎ 0.526⁎⁎⁎
HTGL (activity) −0.295⁎ −0.213 −0.131 0.015 −0.166 −0.187 0.282⁎ 0.231⁎
HTGL (concentration) −0.209 −0.316⁎⁎ −0.094 0.083 −0.062 −0.107 0.178 0.059 0.906⁎⁎⁎
Adiponectin −0.331⁎⁎ 0.445⁎⁎⁎ −0.325⁎⁎ −0.343⁎⁎ −0.421⁎⁎⁎ −0.234⁎ −0.005 0.225 0.005 −0.066
ApoCIII 0.325⁎⁎ 0.170 0.282⁎ 0.209 0.244⁎ 0.214 0.054 0.258⁎ 0.043 0.037 −0.178
Postprandial (20:00)
TG
HDL-C −0.587⁎⁎⁎
sdLDL-C 0.691⁎⁎⁎ −0.416⁎⁎⁎
RLP-C 0.619⁎⁎⁎ −0.471⁎⁎⁎ 0.573⁎⁎⁎
RLP-TG 0.905⁎⁎⁎ −0.616⁎⁎⁎ 0.514⁎⁎⁎ 0.651⁎⁎⁎
RLP-TG/RLP-C 0.780⁎⁎⁎ −0.504⁎⁎⁎ 0.348⁎⁎ 0.248⁎ 0.870⁎⁎⁎
LPL (activity) −0.328⁎⁎ 0.217 −0.093 −0.215 −0.251⁎ −0.204
LPL (concentration) −0.144 0.242⁎ 0.038 0.031 −0.229⁎ −0.308⁎⁎ 0.418⁎⁎⁎
HTGL (activity) −0.075 −0.241⁎ −0.061 0.161 0.094 0.008 0.445⁎⁎⁎ 0.220
HTGL (concentration) 0.199 −0.382⁎⁎ 0.032 0.349⁎⁎ 0.396⁎⁎⁎ 0.269⁎ 0.205 0.102 0.851⁎⁎⁎
Adiponectin −0.475⁎⁎⁎ 0.410⁎⁎⁎ −0.385⁎⁎ −0.396⁎⁎⁎ −0.432⁎⁎⁎ −0.293⁎ 0.036 0.008 0.022 −0.024
ApoCIII 0.555⁎⁎⁎ −0.064 0.448⁎⁎⁎ 0.428⁎⁎⁎ 0.464⁎⁎⁎ 0.340⁎⁎ 0.009 0.412⁎⁎⁎ 0.124 0.247⁎ −0.251⁎
⁎⁎⁎ p b 0.001.
⁎⁎ p b 0.01.
⁎ p b 0.05.
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Table 4
A single regression analysis of these parameters in pre-heparin fasting and postprandial plasma.
TG HDL-C sdLDL-C RLP-C RLP-TG RLP-TG/RLP-C LPL (concentration) HTGL (concentration) Adiponectin ApoCIII
Fasting (8:00)
TG
HDL-C −0.343⁎⁎
sdLDL-C 0.628⁎⁎⁎ −0.299⁎⁎
RLP-C 0.426⁎⁎⁎ −0.212 0.551⁎⁎⁎
RLP-TG 0.859⁎⁎⁎ −0.339⁎⁎ 0.538⁎⁎⁎ 0.519⁎⁎⁎
RLP-TG/RLP-C 0.680⁎⁎⁎ −0.239⁎ 0.200 −0.095 0.751⁎⁎⁎
LPL (concentration) −0.141 0.379⁎⁎ −0.020 −0.103 −0.175 −0.156
HTGL (concentration) – – – – – – –
Adiponectin −0.385⁎⁎ 0.477⁎⁎⁎ −0.344⁎⁎ −0.338⁎⁎ −0.445⁎⁎⁎ −0.324⁎⁎ 0.387⁎⁎ –
ApoCIII 0.449⁎⁎⁎ 0.143 0.383⁎⁎ 0.218 0.436⁎⁎⁎ 0.362⁎⁎ 0.085 – −0.166
Postprandial (20:00)
TG
HDL-C −0.559⁎⁎⁎
sdLDL-C 0.609⁎⁎⁎ −0.381⁎⁎
RLP-C 0.703⁎⁎⁎ −0.408⁎⁎⁎ 0.609⁎⁎⁎
RLP-TG 0.884⁎⁎⁎ −0.550⁎⁎⁎ 0.420⁎⁎⁎ 0.639⁎⁎⁎
RLP-TG/RLP-C 0.524⁎⁎⁎ −0.327⁎⁎ −0.001 −0.019 0.721⁎⁎⁎
LPL (concentration) −0.552⁎⁎⁎ 0.543⁎⁎⁎ −0.284⁎ −0.390⁎⁎ −0.597⁎⁎⁎ −0.435⁎⁎⁎
HTGL (concentration) – – – – – – –
Adiponectin −0.511⁎⁎⁎ 0.436⁎⁎⁎ −0.423⁎⁎⁎ −0.409⁎⁎⁎ −0.465⁎⁎⁎ −0.218 0.352⁎⁎ –
ApoCIII 0.652⁎⁎⁎ −0.065 0.574⁎⁎⁎ 0.532⁎⁎⁎ 0.496⁎⁎⁎ 0.136 −0.152 – −0.294⁎⁎
⁎⁎⁎ p b 0.001.
⁎⁎ p b 0.01.
⁎ p b 0.05.
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with a speciﬁc increase in RLP-TG, which is mainly composed of VLDL
remnants [7,8]. The VLDL remnants, which were not fully metabolized
by lipases and remained in the plasma after food intake, have signiﬁ-
cantly large TG-rich particles. To the best of our knowledge, this is the
ﬁrst report on a relationship between the particle size of remnant lipo-
proteins and the associated LPL and HTGL activities and concentrations
in the fasting and postprandial plasma. We have found that the pre-
heparin plasma LPL concentration displays a high degree of similarity
with post-heparin plasma LPL activity in terms of TRL metabolism,
particularly judging from the comparative study of RLP particle size.
The RLP particle size may be the most appropriate marker to elucidate0.0
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Fig. 1. Correlations of RLP-TG/RLP-C with the LPL activity and concentration in the post-hepar
activity (A) and concentration (B) in the post-heparin plasma in the fasting and postprandial st
(•) plasma.the effect of lipase activities. The slope of the relationship between the
RLP particle size and different variables in the postprandial plasma
was more signiﬁcant than those in the fasting plasma.
We conﬁrmed that the plasma TG, RLP-C, RLP-TG and sdLDL-C con-
centrationswere inversely correlated with LPL activities and concentra-
tion in the post-heparin plasma, as previously reported [3]. However, in
this study population, LPL and HTGL activities and concentrations and
associated lipoproteins in the post-heparin plasmawere not necessarily
consistent between in the fasting and postprandial plasma. This is prob-
ably because lipase activity gradually decreases at room temperature,
which makes it difﬁcult to use effectively for general clinical examina-
tion purposes. Further, it is still a matter of debate as to how much0.0
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Fig. 2. Correlation of RLP-TG/RLP-C ratio between HTGL activity and concentration in the post-heparin plasma in 76 volunteers. Plasma RLP-TG/RLP-C ratio was not correlated with
HTGL activity (A) and concentration (B) in post-heparin plasma in the fasting and postprandial state. Although a signiﬁcantly positive correlation was found between RLP-TG/RLP-C
ratio and HTGL concentration in postprandial state, it means that HTGL does not play a role to hydrolyze RLP. Seventy-six plots reﬂect the total in each volunteer in the fasting (o) and
postprandial (•) plasma.
198 T. Shirakawa et al. / Clinica Chimica Acta 440 (2015) 193–200heparin should be injected and precisely when the post-heparin
sample should be taken in order to obtain the maximum value of LPL
and HTGL activities or concentrations in the post-heparin plasma. For
example, RLP-TG and RLP-TG/RLP-C ratios were almost in parallel
with the LPL activity and concentration in the post-heparin fasting and
postprandial plasma, but RLP-C was only in parallel with LPL activity
and concentration in the fasting plasma, not the postprandial plasma.0.0 50.0 100.0 150.0 200.0 250.0 300.0 350.0 400.0 
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with LPL concentration in post-heparin plasma in both fasting and postprandial state (A) and als
Post-heparin LPL concentration was approximately 10 fold higher in post-heparin plasma than
(o) and postprandial (•) plasma.HDL-C and sdLDL-C displayed a similar trend. The highest similarity
was found between the post-heparin LPL activity in the fasting plasma
and the pre-heparin LPL concentration in the postprandial plasma.
Unexpectedly, HTGL activity in post-heparin plasma was not
correlated with TG, RLP-C, RLP-TG and sdLDL-C both in the fasting
and postprandial plasma. HTGL has been generally believed to have
a role in hydrolyzing small VLDL remnants or IDL in order to form0.0
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199T. Shirakawa et al. / Clinica Chimica Acta 440 (2015) 193–200sdLDL [32,33]. However, our data did not show a correlation between
HTGL activity and either RLPs or sdLDL-C concentration, although we
found a strong inverse correlation between LPL activity and the
sdLDL-C concentration in the same cases. As it is known that sdLDL
is positively correlated with TG and RLPs in plasma [3,33], these
data suggest that RLPs are the precursors of sdLDL and metabolized
mainly in the same pathway by LPL, but not by HTGL. From these
data, HTGL does not seem to play a signiﬁcant role in the metabolic
pathway of remnant lipoprotein metabolism, unlike the studies
reported previously [6,34–37], but rather, plays a deﬁnitive role in
HDL metabolism in human plasma [3].0.00
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Adiponectin was not correlated with LPL activity in post-heparin plasma, but signiﬁcantly an
and postprandial state. Seventy six plots reﬂect the total in each volunteer in the fasting (o) anThe RLP-TG/RLP-C ratio, an estimated index of RLP particle size,
which was ﬁrst reported by Okazaki et al. using an HPLC analysis [9],
was found to be inversely correlatedwith LPL activity and concentration
in both the pre- and post-heparin plasma, but no correlation was found
with theHTGL activity or concentration. The pre-heparin LPL concentra-
tion was also inversely correlated with RLP-TG/RLP-C ratio in the post-
prandial plasma in similar fashion to the post-heparin plasma LPL
activity. Although the RLP-TG/RLP-C ratio in pre-heparin plasma exhib-
ited a trend of being inversely correlated with the LPL concentration in
the fasting plasma, it was not statistically signiﬁcant, probably because
of a low TG concentration in the fasting plasma.A
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200 T. Shirakawa et al. / Clinica Chimica Acta 440 (2015) 193–200Adiponectin is a plasma protein expressed in adipose tissue that is
known to be closely associated with LPL and cardiovascular risk [38].
Interestingly, adiponectin in pre-heparin plasma was inversely and
signiﬁcantly correlated with the RLP-TG/RLP-C ratio and positively
correlated with LPL concentration, but adiponectin was not correlated
with LPL activity in post-heparin plasma. These results indicate that
LPL concentration in pre-heparin plasma is more physiologically associ-
ated with adiponectin than the maximum LPL activity or concentration
dissociated from endothelium after heparin injection. Therefore, LPL ac-
tivity or concentrationwhenmeasured in post-heparin plasmamay not
reﬂect the physiological condition on TG-rich lipoprotein metabolism.
LPL concentration in pre-heparin plasma may present more diagnostic
usefulness than the measurement of LPL activity in post-heparin
plasma. Apo CIII is a well-known inhibitor of LPL activity [39]. However,
therewas nodirect correlation between LPL activity and apoCIII concen-
tration in the fasting and postprandial plasma (Table 3). However,
apoCIII was positively correlated with the RLP-TG/RLP-C ratio, as
shown correlated with RLP-C and RLP-TG, respectively [40], but it
does not seem to inhibit LPL activity directly in plasma. ApoCIII may
exert an inhibitory effect on the receptors which are associated with
the ligand function of LPL rather than inhibiting the lypolytic activity
of LPL. ApoC1 seems to be more direct inhibitor of LPL in RLP [41].
In conclusion, a signiﬁcantly increased particle size of RLP, estimated
by the RLP-TG/RLP-C ratio, was observed in the postprandial plasma.
LPL activity and concentration in post-heparin plasma were inversely
correlated with the RLP particle size, but HTGL was not. These results
suggest that RLPs are mainly metabolized by LPL in both the post-
heparin and pre-heparin plasma. LPL was positively correlated with
adiponectin levels, but not with the apoCIII levels. As RLPTG/RLP-C
ratio and other lipoproteins in TRL metabolism were shown to be in-
versely correlated with LPL activity (post-heparin) and concentration
(pre-heparin) in the same manner, LPL concentration in the pre-
heparin plasma may effectively take the place of LPL activity in the
post-heparin plasma for clinical diagnosis purpose.
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